Cargando…

The possible regions to design Human Papilloma Viruses vaccine in Iranian L1 protein

Human Papilloma Virus (HPV) genome encodes several proteins, as L1is major capsid protein and L2 is minor capsid protein. Among all HPV types HPV-16 and HPV-18 are the most common high-risk HPV (HR-HPV) types globally and the majority of cases are infected with these types. HPV entry and the initial...

Descripción completa

Detalles Bibliográficos
Autores principales: Dehghani, Behzad, Hasanshahi, Zahra, Hashempour, Tayebeh, Motamedifar, Mohamad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7223900/
https://www.ncbi.nlm.nih.gov/pubmed/32435064
http://dx.doi.org/10.2478/s11756-019-00386-w
_version_ 1783533813074231296
author Dehghani, Behzad
Hasanshahi, Zahra
Hashempour, Tayebeh
Motamedifar, Mohamad
author_facet Dehghani, Behzad
Hasanshahi, Zahra
Hashempour, Tayebeh
Motamedifar, Mohamad
author_sort Dehghani, Behzad
collection PubMed
description Human Papilloma Virus (HPV) genome encodes several proteins, as L1is major capsid protein and L2 is minor capsid protein. Among all HPV types HPV-16 and HPV-18 are the most common high-risk HPV (HR-HPV) types globally and the majority of cases are infected with these types. HPV entry and the initial interaction with the host cell are mainly related to the L1 protein which is the main component of HPV vaccines. The aim of this research was comparison analysis among all Iranian L1 protein sequences submitted in NCBI GenBank to find the major substitutions as well as structural and immune properties of this protein. All sequences HPV L1 protein from Iranian isolates from 2014 to 2016 were selected and obtained from NCBI data bank. “CLC Genomics Workbench” was used to translate alignment. To predict B cell epitopes, we employed several programs. Modification sites such as phosphorylation, glycosylation, and disulfide bonds were determined. Secondary and tertiary structures of all sequences were analyzed. Several mutations were found and major mutations were in amino acid residues 102, 202, 207, 292, 379, and 502. The mentioned mutations showed the minor effect on B cell and physicochemical properties of the L1 protein. Six disulfide bonds were determined in L1 protein and also in several N-link glycosylation and phosphorylation sites. Five L1 loops were determined, which had great potential to be B cell epitopes with high antigenic properties. All in all, this research as the first report from Iran described the tremendous potential of two L1 loops (BC and FG) to induce immune system which can be used as the descent candidate to design a new vaccine against HPV in the Iranian population. In addition, some differences between the reference sequence and Iranian patients’ sequences were determined. It is essential to consider these differences to monitor the effectiveness and efficacy of the vaccine for the Iranian population. Our results provide a vast understanding of L1 protein that can be useful for further studies on HPV infections and new vaccine generations.
format Online
Article
Text
id pubmed-7223900
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-72239002020-05-15 The possible regions to design Human Papilloma Viruses vaccine in Iranian L1 protein Dehghani, Behzad Hasanshahi, Zahra Hashempour, Tayebeh Motamedifar, Mohamad Biologia (Bratisl) Original Article Human Papilloma Virus (HPV) genome encodes several proteins, as L1is major capsid protein and L2 is minor capsid protein. Among all HPV types HPV-16 and HPV-18 are the most common high-risk HPV (HR-HPV) types globally and the majority of cases are infected with these types. HPV entry and the initial interaction with the host cell are mainly related to the L1 protein which is the main component of HPV vaccines. The aim of this research was comparison analysis among all Iranian L1 protein sequences submitted in NCBI GenBank to find the major substitutions as well as structural and immune properties of this protein. All sequences HPV L1 protein from Iranian isolates from 2014 to 2016 were selected and obtained from NCBI data bank. “CLC Genomics Workbench” was used to translate alignment. To predict B cell epitopes, we employed several programs. Modification sites such as phosphorylation, glycosylation, and disulfide bonds were determined. Secondary and tertiary structures of all sequences were analyzed. Several mutations were found and major mutations were in amino acid residues 102, 202, 207, 292, 379, and 502. The mentioned mutations showed the minor effect on B cell and physicochemical properties of the L1 protein. Six disulfide bonds were determined in L1 protein and also in several N-link glycosylation and phosphorylation sites. Five L1 loops were determined, which had great potential to be B cell epitopes with high antigenic properties. All in all, this research as the first report from Iran described the tremendous potential of two L1 loops (BC and FG) to induce immune system which can be used as the descent candidate to design a new vaccine against HPV in the Iranian population. In addition, some differences between the reference sequence and Iranian patients’ sequences were determined. It is essential to consider these differences to monitor the effectiveness and efficacy of the vaccine for the Iranian population. Our results provide a vast understanding of L1 protein that can be useful for further studies on HPV infections and new vaccine generations. Springer International Publishing 2019-12-24 2020 /pmc/articles/PMC7223900/ /pubmed/32435064 http://dx.doi.org/10.2478/s11756-019-00386-w Text en © Institute of Molecular Biology, Slovak Academy of Sciences 2019 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Original Article
Dehghani, Behzad
Hasanshahi, Zahra
Hashempour, Tayebeh
Motamedifar, Mohamad
The possible regions to design Human Papilloma Viruses vaccine in Iranian L1 protein
title The possible regions to design Human Papilloma Viruses vaccine in Iranian L1 protein
title_full The possible regions to design Human Papilloma Viruses vaccine in Iranian L1 protein
title_fullStr The possible regions to design Human Papilloma Viruses vaccine in Iranian L1 protein
title_full_unstemmed The possible regions to design Human Papilloma Viruses vaccine in Iranian L1 protein
title_short The possible regions to design Human Papilloma Viruses vaccine in Iranian L1 protein
title_sort possible regions to design human papilloma viruses vaccine in iranian l1 protein
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7223900/
https://www.ncbi.nlm.nih.gov/pubmed/32435064
http://dx.doi.org/10.2478/s11756-019-00386-w
work_keys_str_mv AT dehghanibehzad thepossibleregionstodesignhumanpapillomavirusesvaccineiniranianl1protein
AT hasanshahizahra thepossibleregionstodesignhumanpapillomavirusesvaccineiniranianl1protein
AT hashempourtayebeh thepossibleregionstodesignhumanpapillomavirusesvaccineiniranianl1protein
AT motamedifarmohamad thepossibleregionstodesignhumanpapillomavirusesvaccineiniranianl1protein
AT dehghanibehzad possibleregionstodesignhumanpapillomavirusesvaccineiniranianl1protein
AT hasanshahizahra possibleregionstodesignhumanpapillomavirusesvaccineiniranianl1protein
AT hashempourtayebeh possibleregionstodesignhumanpapillomavirusesvaccineiniranianl1protein
AT motamedifarmohamad possibleregionstodesignhumanpapillomavirusesvaccineiniranianl1protein